• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

较高的非酒精性脂肪性肝病纤维化评分与肾小球滤过率受损相关。

Higher NAFLD fibrosis score is associated with impaired eGFR.

机构信息

Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC; Department of Occupational and Environmental Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC; Faculty of Internal Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, ROC; Hepatobiliary Section, Department of Internal Medicine, and Hepatitis Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan, ROC.

Health Management Center, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, ROC.

出版信息

J Formos Med Assoc. 2020 Jan;119(1 Pt 3):496-503. doi: 10.1016/j.jfma.2019.07.007. Epub 2019 Jul 25.

DOI:10.1016/j.jfma.2019.07.007
PMID:31353118
Abstract

BACKGROUND/PURPOSE: Chronic kidney disease (CKD) has become a worldwide health problem, leading to high morbidity and mortality, and non-alcoholic fatty liver disease (NAFLD) is considered a risk factor for CKD. The aim of this study was to explore the relationship between NAFLD fibrosis score (NFS) and the estimated glomerular filtration rate (eGFR), and identify possible risk factors related to the NFS among Taiwanese subjects.

METHODS

Subjects were enrolled from the database of the Department of Preventive Medicine of Kaohsiung Municipal Hsiao-Kang Hospital. The eGFR was calculated according to the Taiwanese Modification of Diet in Renal Disease (TMDRD) equation, and the NFS was employed to evaluate the fibrotic level.

RESULTS

In total, 11,376 subjects were enrolled in this study, with a mean age of 52.0 ± 6.81 years, including 4529 (39.8%) males. A fasting sugar level ≥100 mg/dL (OR = 1.70, 95% CI = 1.52-1.87) and an abnormal waist circumference (OR = 1.81, 95% CI = 1.65-1.99) were significant factors associated with NFS (p < 0.05). Trends of a decreasing TMDRD score and an increasing NFS with increasing age were noted (p < 0.05). The NFS was significantly negatively correlated with the TMDRD score (standard coefficients: -0.067, p < 0.001).

CONCLUSION

A higher NFS is associated with an impaired eGFR in Taiwanese subjects. Controlling risk factors, especially fasting sugar level and waist circumference, may be useful in preventing NFS deterioration, which is negatively correlated with the eGFR.

摘要

背景/目的:慢性肾脏病(CKD)已成为全球性的健康问题,导致高发病率和死亡率,非酒精性脂肪性肝病(NAFLD)被认为是 CKD 的一个危险因素。本研究旨在探讨 NAFLD 纤维化评分(NFS)与估算肾小球滤过率(eGFR)之间的关系,并确定台湾人群中与 NFS 相关的可能危险因素。

方法

本研究从高雄小港医院预防医学科的数据库中招募了受试者。根据台湾改良肾脏病饮食法(TMDRD)方程计算 eGFR,并用 NFS 评估纤维化程度。

结果

本研究共纳入了 11376 名受试者,平均年龄为 52.0±6.81 岁,其中 4529 名(39.8%)为男性。空腹血糖水平≥100mg/dL(OR=1.70,95%CI=1.52-1.87)和腰围异常(OR=1.81,95%CI=1.65-1.99)是与 NFS 相关的显著因素(p<0.05)。随着年龄的增长,TMDRD 评分下降和 NFS 增加的趋势明显(p<0.05)。NFS 与 TMDRD 评分显著负相关(标准系数:-0.067,p<0.001)。

结论

在台湾人群中,较高的 NFS 与 eGFR 受损有关。控制危险因素,特别是空腹血糖水平和腰围,可能有助于防止 NFS 恶化,而 NFS 与 eGFR 呈负相关。

相似文献

1
Higher NAFLD fibrosis score is associated with impaired eGFR.较高的非酒精性脂肪性肝病纤维化评分与肾小球滤过率受损相关。
J Formos Med Assoc. 2020 Jan;119(1 Pt 3):496-503. doi: 10.1016/j.jfma.2019.07.007. Epub 2019 Jul 25.
2
Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA.美国非酒精性脂肪肝成人中的非侵入性纤维化标志物与慢性肾脏病
Eur J Gastroenterol Hepatol. 2018 Apr;30(4):404-410. doi: 10.1097/MEG.0000000000001045.
3
Lower eGFR is associated with increased probability of liver fibrosis in Chinese diabetic patients.较低的 eGFR 与中国糖尿病患者肝纤维化的概率增加相关。
Diabetes Metab Res Rev. 2020 Jul;36(5):e3294. doi: 10.1002/dmrr.3294. Epub 2020 Feb 17.
4
New Nonalcoholic Fatty Liver Disease and Fibrosis Progression Associate With the Risk of Incident Chronic Kidney Disease.新的非酒精性脂肪性肝病和纤维化进展与慢性肾脏病发病风险相关。
J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3957-e3968. doi: 10.1210/clinem/dgab425.
5
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank.非酒精性脂肪肝疾病和肝纤维化对慢性肾脏病患者不良临床结局和死亡率的影响:利用英国生物库的前瞻性队列研究。
BMC Med. 2023 May 18;21(1):185. doi: 10.1186/s12916-023-02891-x.
6
Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.非酒精性脂肪性肝病相关慢性肾脏病患者肾小球滤过率估计值低的非侵入性纤维化评估:福冈肾脏病登记研究。
Clin Exp Nephrol. 2021 Aug;25(8):822-834. doi: 10.1007/s10157-020-02018-z. Epub 2021 Apr 15.
7
The correlation between fatty liver disease and chronic kidney disease.脂肪肝疾病与慢性肾病之间的相关性。
J Formos Med Assoc. 2020 Jan;119(1 Pt 1):42-50. doi: 10.1016/j.jfma.2019.02.010. Epub 2019 Mar 12.
8
Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD).非侵入性纤维化评分系统可预测非酒精性脂肪性肝病(NAFLD)患者未来的代谢并发症及总体死亡率。
Scand J Gastroenterol. 2019 Mar;54(3):328-334. doi: 10.1080/00365521.2019.1583366. Epub 2019 Mar 23.
9
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.非酒精性脂肪性肝病纤维化评分高可预测颈动脉斑块形成:基于中国常规健康检查数据的回顾性队列研究。
Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081.
10
Fibrosis Risk in Nonalcoholic Fatty Liver Disease Is Related to Chronic Kidney Disease in Older Type 2 Diabetes Patients.非酒精性脂肪性肝病的纤维化风险与老年 2 型糖尿病患者的慢性肾脏病有关。
J Clin Endocrinol Metab. 2022 Aug 18;107(9):e3661-e3669. doi: 10.1210/clinem/dgac382.

引用本文的文献

1
Metabolic Dysfunction Associated-Steatotic Liver Disease (MASLD) and Cardiovascular Risk: Embrace All Facets of the Disease.代谢功能障碍相关脂肪性肝病(MASLD)与心血管风险:全面认识该疾病的各个方面。
Curr Cardiol Rep. 2025 Jan 13;27(1):19. doi: 10.1007/s11886-024-02181-9.
2
The Association Between Non-Clinically Apparent Liver Fibrosis and Pulmonary Arterial Hypertension in Hispanic Patients.西班牙裔患者非临床显性肝纤维化与肺动脉高压之间的关联
Cardiol Res. 2023 Dec;14(6):429-436. doi: 10.14740/cr1565. Epub 2023 Dec 9.
3
Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver.
代谢相关脂肪性肝病(MAFLD):一种超越肝脏的多系统疾病。
J Clin Transl Hepatol. 2022 Apr 28;10(2):329-338. doi: 10.14218/JCTH.2021.00178. Epub 2021 Oct 19.
4
Non-alcoholic fatty liver and chronic kidney disease: Retrospect, introspect, and prospect.非酒精性脂肪性肝病与慢性肾脏病:回顾、反思与展望
World J Gastroenterol. 2021 May 7;27(17):1864-1882. doi: 10.3748/wjg.v27.i17.1864.
5
Study on the correlation between urinary retinol-binding protein and nonalcoholic fatty liver disease.尿视黄醇结合蛋白与非酒精性脂肪性肝病的相关性研究
J Med Biochem. 2021 Jan 26;40(1):86-91. doi: 10.5937/jomb0-24666.
6
Association between Non-Alcoholic Fatty Liver Disease and Chronic Kidney Disease: A Cross-Sectional Study.非酒精性脂肪性肝病与慢性肾脏病的关联:一项横断面研究。
J Clin Med. 2020 May 28;9(6):1635. doi: 10.3390/jcm9061635.